ANTIOXIDANT ASSAY OF PHASEOLUS VULGARIS L BEANS ETHANOLIC EXTRACT IN VITRO AND IN VIVO

  • Dwi Rita Anggraini Department of Anatomy, Faculty of Medicine, Universitas Sumatera Utara, Jalan dr. Mansur, USU-Kampus, Medan 20155, Indonesia.
  • Tri Widyawati Department of Pharmacology and Therapeutic, Faculty of Medicine, Universitas Sumatera Utara, Jalan dr. Mansur, USU-Kampus, Medan 20155, Indonesia.
  • Mutiara Indah Sari Department of Biochemistry, Faculty of Medicine, Universitas Sumatera Utara, Jalan dr. Mansur, USU-Kampus, Medan 20155, Indonesia.
  • Henny Sri Wahyuni Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universitas Sumatera Utara, Jalan Almamater, USUKampus, Medan 20155, Indonesia.
  • Siti Syarifah Department of Anatomy, Faculty of Medicine, Universitas Sumatera Utara, Jalan dr. Mansur, USU-Kampus, Medan 20155, Indonesia.
  • Ade Putra Fratamasinaga Department of Biomedical Science, Faculty of Medicine, Universitas Sumatera Utara, Jalan dr. Mansur, USU-Kampus, Medan 20155, Indonesia.
  • Maya Anjelir Antika Department of Biomedical Science, Faculty of Medicine, Universitas Sumatera Utara, Jalan dr. Mansur, USU-Kampus, Medan 20155, Indonesia.

Abstract

Objectives: Antioxidant is a substance such as Vitamin C that able to remove potentially damaging oxidizing agents. Malondialdehyde (MDA) is an important marker of oxidative stress that have correlation with Type 2 diabetes mellitus (DM) progression. Phaseolus vulgaris L (PV) (beans) is one of the alternative medicines to treat DM in Indonesia. We investigated the antioxidant activity of ethanolic extract on PV (EEPV) beans using in vitro and in vivo model.

Methods: Antioxidant assay in vitro was conducted using 1,1-diphenyl-2-picrylhydrazyl (DPPH) method. Alloxan (120 mg/kg, intraperitoneally)- induced diabetic rats were divided into 5 groups (n=5), i.e., NC: Normal control, P1: Diabetic-control, P2, P3, and P4 (200 mg/kg, 400 mg/kg, and 600 mg/kg of EEPV, orally) for 28 days. MDA serum level was evaluated using spectrophotometer. The data were analyzed by one-way ANOVA test.

Results: The antioxidant assay in vitro showed that EEPV has very weak (IC50=641.87 μg/ml, whereas Vitamin C as standard showed very strong activity (IC50=2.95 μg/ml). MDA level were 2.80±0.09 nmol/ml (NC), 3.30±0.42 nmol/ml (P1), 3.27±4.23 nmol/ml (P2), 2.93±0.05 nmol/ml (P3), and 3.17±0.25 nmol/ml (P4). There was no significant differences among normal control, diabetic-control, and EEPV-treated groups (p>0.05).

Conclusion: EEPV showed a very weak antioxidant activity in vitro.

Keywords: Antioxidant, Phaseoleus vulgaris L, Beans, Ethanolic extract, In vitro, In vivo.

References

1. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol 2005;4:5.
2. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes 1991;40:405-12.
3. Young WK, Tatiana VB. Oxidative stress in angiogenesis and vacular disease. Blood 2014;123:5.
4. Yoshikawa T, Naito Y. What is oxidative stress? J Japan Med Assoc 2002;45:217-76.
5. Antonio A, Mario FM, Sandro A. Lipid peroxidation: Production metabolism and signalling mechanism of malonaldehyde and 4-hydroxy-2-Nonenal. Oxid Med Cell Longev 2014; ???:1-13.
6. Sitorus MS, Anggraini DR, Hidayat. Decreasing free radicals level on high risk person after vitamin C and E supplement treatment. In IOP conference series. Mater Sci Eng 2017;180:12093.
7. Broughton WJ, Herna´ndez G, Blair M, Beebe S, Gepts P, Vanderleyden J. Beans (Phaseolus spp.)–model food legumes. Plant Soil 2003;252:55-128.
8. Venkateswaran S, Pari L. Antioxidant effect of Phaseolus vulgaris in streptozotocin-induced diabetic rats. Asia Pac J Clin Nutr 2002;11:206-9.
9. Golbidi S, AlirezaEbadi S, Laher I. Antioxidants in the treatment of diabetes. Curr Diabetes Rev 2011;7:106-25.
10. Chougale AD, Panaskar SN, Gurao PM, Arvindeka AU. Optimization of Alloxan dose is Essential to Induce Stable Diabetes for Prolong Period; 2007. Available from: http://www.sciarlet.net/ fulltext/?doi=ajb2007.402.408.
11. Nugroho AE. Animal models of diabetes mellitus : Pathology and mechanism of some diabetogenics. Biodivers J Biol Divers 2006;7:378-82.
12. Molyneux P. The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J Sci Technol 2004;26:211-9.
13. Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev 2009;89:27-71.
14. Carai MA, Fantini N, Loi B, Colombo G, Riva A, Morazzoni P. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Targ Therap 2009;2:149-53.
15. Mishra SB, Rao CV, Ojha SK, Vijayakumar M, Verma A. An analytical review of plants for anti-diabetic activity with their phytoconstituent and mechanism of action: A review. Int J Pharm Sci Res 2010;1:29-44.
16. Nimse SB, Pal D. Free radicals, natural antioxidants, and their reaction mechanisms. Rsc Adv 2015;5:27986-8006.
17. Rice-Evans C, Miller N, Paganga G. Antioxidant properties of phenolic compounds. Trends Plant Sci 1997;2:152-9.
18. Mensor LL, Menezes FS, Leitão GG, Reis AS, dos Santos TC, Coube CS, et al. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method. Phytother Res 2001;15:127-30.
19. Mahboob M, Rahman MF, Grover P. Serum lipidperoxidation and antioxidant enzyme levels in maleand female diabetic patients. Singapore Med J 2005;46:322-4.
20. Kumawat M, Singh I, Singh N, Singh V, Kharb S. Lipid peroxidation and lipid profilein Type II diabetes mellitus. WebmedCentral Biochem 201;3:WMC003147.
21. Laight DW, Carrier MJ, Anggård EE. Antioxidants, diabetes and endothelial dysfunction. Cardiovasc Res 2000;47:457-64.
Statistics
193 Views | 204 Downloads
Citatons
How to Cite
Anggraini, D. R., T. Widyawati, M. I. Sari, H. S. Wahyuni, S. Syarifah, A. P. Fratamasinaga, and M. A. Antika. “ANTIOXIDANT ASSAY OF PHASEOLUS VULGARIS L BEANS ETHANOLIC EXTRACT IN VITRO AND IN VIVO”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 13, Apr. 2018, pp. 122-5, doi:10.22159/ajpcr.2018.v11s1.26584.
Section
Original Article(s)